Tutti gli studi
Attivo ma non reclutanteFASE3INTERVENTISTICO

Study to Evaluate the Safety and Efficacy of Pegvaliase in Adolescents (Ages 12-17) With Phenylketonuria

This study is for young people aged 12 to 17 who have a condition called Phenylketonuria, or PKU. PKU means your body has trouble breaking down a substance called phenylalanine, which can cause health problems. The study is testing a new injectable medicine called pegvaliase to see if it helps manage PKU better than just a special diet alone. Some participants will receive the pegvaliase injection, and others will continue with their usual PKU diet. Researchers want to find out if this new treatment is both safe and effective in controlling phenylalanine levels in the blood. If you or a teenager you know has PKU and might be interested, reading the full details will help you understand more.

A colpo d'occhio

Stato
Attivo ma non reclutante
Fase
FASE3
Sponsor
BioMarin Pharmaceutical
Obiettivo di iscrizione
55
Inizio
17 Jun 2022
Completamento stimato
01 Ott 2027

Di cosa tratta questo studio?

Phenylketonuria, or PKU, is a rare condition that babies are usually tested for at birth. If you have PKU, your body can't properly break down an important part of food called phenylalanine. When too much phenylalanine builds up in the blood, it can cause health problems. People with PKU typically need to follow a very strict diet throughout their lives to keep their phenylalanine levels under control, and sometimes they also take other medicines.

This study, called a Phase 3 study, is looking at a new medicine called pegvaliase. Researchers want to see if this medicine, given as an injection, can help teenagers aged 12 to 17 who have PKU. It's for those whose phenylalanine levels are still too high, even with their current treatment which usually involves a special diet. The goal is to find out if pegvaliase is safe and if it helps to lower and control phenylalanine levels better than just relying on diet alone.

In this study, some teenagers will receive the pegvaliase injection every day, while others will continue to manage their PKU using only their special diet. By comparing these two groups, the researchers hope to understand if pegvaliase can offer a new and effective way to help young people with PKU live healthier lives.

Punti chiave

  • This study is testing a new injection (pegvaliase) for teenagers with PKU.
  • It aims to see if pegvaliase is safe and effective in lowering high phenylalanine levels.
  • Participants will either receive the injection or continue with their special PKU diet.
  • A parent or guardian adult must help with injections and monitoring.
  • The study involves regular clinic visits for checks and blood tests.
  • La partecipazione è volontaria e puoi ritirarti in qualsiasi momento.

Chi può essere idoneo?

This study is looking for teenagers aged 12 to 17 (in the UK, this is usually up to 15 for some aspects) who have been diagnosed with PKU. It's important that your current treatment, even if it includes special diets or other medicines, hasn't been able to consistently keep your blood phenylalanine levels low enough. Specifically, your levels need to have been above 600 μmol/L on a couple of recent tests, and generally high over the last year.

You and your family must be willing to work closely with a study dietitian to stick to the special diet required by the study. If you take medication for conditions like ADHD or depression, you need to have been on a stable dose for at least 8 weeks before joining. Also, an adult aged 18 or over must be available and willing to help you with the daily injection and watch you for about an hour afterwards.

There are also some reasons you wouldn't be able to join. For example, if you've ever had pegvaliase before. You also can't be taking any other PKU medicines, or certain types of injectable drugs that contain a substance called polyethylene glycol (PEG), within a specific time before or during the study, unless it's for something like contraception that's been discussed with the study team.

Questo studio potrebbe fare al caso tuo?

Rispondi a queste domande rapide per vedere se potresti essere idoneo. Questo è solo una guida — il team di ricerca prende la decisione finale.

  1. Hai tra i 12 e i 17 anni?
  2. Do you have PKU, and your phenylalanine levels are often too high?
  3. Are you willing to follow a special diet guided by a dietitian?
  4. Is there an adult (18+) who can help you with daily injections and watch you afterwards?
  5. Have you *not* had pegvaliase treatment before?
  6. Are you able to avoid other specific PKU medicines during the study?
Rispondi a ogni domanda per vedere il tuo risultato.

Cosa comporta la partecipazione?

If you decide to take part in this study, you'll first have a screening period to make sure you're a good fit. During the study, you would be randomly placed into one of two groups: either you'll receive the pegvaliase injection every day, or you'll continue to manage your PKU with your special diet alone. You won't get to choose which group you're in, as this helps make the study fair.

The pegvaliase is given as a daily injection. An adult will need to be present to help you with this and to watch you for about an hour afterwards for any reactions. You'll also work closely with a study dietitian to manage your food intake according to the study's plan. Throughout the study, you'll have regular appointments at the clinic for assessments, which will include blood tests to check your phenylalanine levels and monitor your general health. These visits will help the doctors see how you are doing and if the treatment is working. The total duration of the study would be discussed in detail by the study team, including how long you would be receiving the study treatment and how often you'd need to visit the clinic.

Rischi e benefici potenziali

Taking part in any study has potential benefits and risks. A potential benefit of this study is that the pegvaliase injection might help to lower your phenylalanine levels more effectively than your current treatment, which could improve your health and quality of life. However, it's also possible that the treatment might not work for you, or it could cause side effects. Like all medicines, pegvaliase might have some side effects, which you would be fully informed about before deciding to join. The study team will carefully monitor you for any problems. Remember, taking part is completely voluntary, and you are free to withdraw from the study at any time, for any reason, without it affecting your usual medical care.

Locations (16)

  • Phoenix Children's Hospital
    Codice postale verificato
    Phoenix, Stati Uniti
  • Arkansas Children's Hospital
    Codice postale verificato
    Little Rock, Stati Uniti
  • Ospedale Pediatrico del Colorado
    Codice postale verificato
    Aurora, Stati Uniti
  • University of South Florida
    Codice postale verificato
    Tampa, Stati Uniti
  • Ann and Robert H. Lurie Children's Hospital of Chicago
    Codice postale verificato
    Chicago, Stati Uniti
  • IU Health University Hospital
    Codice postale verificato
    Indianapolis, Stati Uniti
  • University of Kentucky College of Medicine
    Codice postale verificato
    Lexington, Stati Uniti
  • Ospedale Pediatrico di Boston
    Codice postale verificato
    Boston, Stati Uniti
  • University of Pittsburgh Medical Center
    Codice postale verificato
    Pittsburgh, United States
  • McGovern Medical School, University of Texas Health Science Center at Houston (UTHealth)
    Codice postale verificato
    Houston, Stati Uniti
  • University of Utah Medical Center
    Codice postale verificato
    Salt Lake City, United States
  • University of Virginia School of Medicine
    Codice postale verificato
    Charlottesville, United States

Domande comuni

What is PKU?

PKU, or Phenylketonuria, is a condition where your body can't properly break down a substance called phenylalanine found in food. This can lead to health problems if not controlled.

What is pegvaliase?

Pegvaliase is a new medicine, given as an injection, that researchers are testing to help people with PKU manage their phenylalanine levels.

Quanto durerà lo studio?

The full duration of the study, including initial screening, treatment period, and follow-up, will be clearly explained by the study team if you are suitable to participate.

Dovrò pagare per partecipare allo studio?

No, you will not have to pay to participate in the study. All study-related care and medication will be provided by the study.

Posso abbandonare lo studio se cambio idea?

Yes, you can choose to leave the study at any time, for any reason, without it affecting your usual medical care.

Come saperne di più

Parla sempre con il tuo medico di base o specialista prima di decidere di partecipare a uno studio.

Discussione

Discussione della comunità

Supportato dal nostro forum su community.patient.info. Si prega di essere rispettosi — questo non è un consiglio medico.